1999
DOI: 10.1523/jneurosci.19-24-10898.1999
|View full text |Cite
|
Sign up to set email alerts
|

Cerebral Microvascular Obstruction by Fibrin is Associated with Upregulation of PAI-1 Acutely after Onset of Focal Embolic Ischemia in Rats

Abstract: The mechanisms underlying cerebral microvascular perfusion deficit resulting from occlusion of the middle cerebral artery (MCA) require elucidation. We, therefore, tested the hypothesis that intravascular fibrin deposition in situ directly obstructs cerebral microcirculation and that local changes in type 1 plasminogen activator inhibitor (PAI-1) gene expression contribute to intravascular fibrin deposition after embolic MCA occlusion. Using laser-scanning confocal microscopy (LSCM) in combination with immunof… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
109
0
1

Year Published

2004
2004
2021
2021

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 122 publications
(116 citation statements)
references
References 39 publications
6
109
0
1
Order By: Relevance
“…7 Surprisingly, intravenous injection of tPA in such stroke models still has a beneficial component through the degradation of endogenous deposits of fibrin that takes place in the ischemic tissue. 27,28 Another key point of the debate is the dose of tPA used to achieve reperfusion. Because human tPA (found in Actilyse) is 10-fold less efficient in activating rodent plasminogen than endogenous rodent tPA, the dose used in animals is usually 10 mg/kg, corresponding to 10-fold the dose used in humans, which leads to a complex interpretation of the data.…”
Section: Discussionmentioning
confidence: 99%
“…7 Surprisingly, intravenous injection of tPA in such stroke models still has a beneficial component through the degradation of endogenous deposits of fibrin that takes place in the ischemic tissue. 27,28 Another key point of the debate is the dose of tPA used to achieve reperfusion. Because human tPA (found in Actilyse) is 10-fold less efficient in activating rodent plasminogen than endogenous rodent tPA, the dose used in animals is usually 10 mg/kg, corresponding to 10-fold the dose used in humans, which leads to a complex interpretation of the data.…”
Section: Discussionmentioning
confidence: 99%
“…Flat-mounted retinas show microthromboemboli (Figure 2), as observed in acute ischemic rat brains. 16 The early and transient upregulation of PAI1 triggers vascular fibrin deposition and contributes to the stabilization and growth of arterial thrombi by abolishing fibrinolysis. 4 We observed a decrease in PAI1 mRNA levels 1 hour after reperfusion.…”
Section: Discussionmentioning
confidence: 99%
“…Platelets, along with thrombin and fibrin resulting from tissue factoractivated blood coagulation, are the primary contributors to thrombus development at the site of the occluded artery (14,15). Concomitantly, occlusion of a major cerebral artery triggers development of secondary thrombosis in downstream microvessels, which causes dysfunction of cerebral endothelial cells, pericytes, and astrocytes and leads to disruption of the blood-brain barrier (BBB) and ischemic cell damage (16)(17)(18)(19). The evolution of downstream microvascular thrombosis is heterogeneous and continues for hours and is highly associated with the progression of ischemic neuronal death from reversible to irreversible damage (14,(16)(17)(18).…”
Section: Pathophysiology Of Ischemic Strokementioning
confidence: 99%